(580 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA position paperAbstract Further to the approval of the Coronavirus disease 2019 (COVID-19) vaccine BNT16...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Molecular Allergology User's Guide 2.0The First Edition of “EAACI Molecular Allergology User’s Guide” was released in 20...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensusAbstract Background: Although there are many asymptomatic patients, one of the problems ...
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - An EAACI/ARIA position paperAbstract Background: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic...
-
ERS/EAACI statement on adherence to international adult asthma guidelinesAbstract Guidelines aim to standardise and optimise asthma diagnosis and management. Neve...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescentsAbstract Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatri...
Show more Consensus Documents (10)Show Less-
-
ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paperCoronavirus disease 2019 (COVID‐19) vaccine BNT162b2 received approval and within the fi...
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccinesWe provide a simplified algorithm of prevention, diagnosis and treatment of severe allergi...
-
Is there a role for childhood vaccination against COVID-19?Tremendous efforts are undertaken to quickly develop COVID‐19 vaccines that protect vuln...
-
Atopic status protects from severe complications of COVID‐19In conclusion, atopic status seems to protect against the most severe, often fatal consequ...
-
African American children are at higher risk for COVID‐19 infection“Infection by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the ...
-
Risk factors for severe and critically ill COVID-19 patients: A reviewIntranasal corticosteroids remain the standard treatment for CRS in patients with SARS‐C...
-
Vaccines and allergic reactions: the past, the current COVID‐19 pandemic, and future perspectivesAbstract Vaccines are essential public health tools with a favorable safety profile and pr...
-
Angiotensin‐converting enzyme II expression and its implication in the association between COVID‐19 and allergic rhinitisIn conclusion, for the first time, we provide the evidence that AR comorbidity may not hav...
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold - an ARIA- EAACI - GA2LEN consensusAlthough there are many asymptomatic patients, one of the problems of COVID‐19 is early ...
-
Blood myeloperoxidase‐DNA, a biomarker of early response to SARS‐CoV‐2 infection?In conclusion, our results on a consecutive ambulatory population of COVID‐19 cases sugg...
-
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infectionsOur findings might have important implications for the definition of asymptomatic COVID‐...
-
Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitisIn summary, our study provides the first evidence of regional differences in ACE2 expressi...
-
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsIn conclusion, in our large cohort of severe asthmatics, only a small minority experienced...
-
Genetic Predisposition to allergic diseases is inversely associated to risk of COVID-19Allergic diseases such as allergic rhinitis (hay fever), atopic dermatitis (eczema) and as...
-
COVID-19 Pandemic and allergen immunotherapy - an EAACI surveyAs in many fields of medical care, the coronavirus disease 2019 (COVID‐19) resulted in a...
-
Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in BeijingThe results support the recommendation that patients continue taking their prescribed asth...
-
Delayed virus‐specific antibody responses associate with COVID‐19 mortalityCollectively, for the first time, our study provides evidence that delayed antibody respon...
-
Pros and Cons for the role of air pollution on COVID-19 DevelopmentAs SARS‐CoV‐2 has spread across the globe, it has been difficult to ignore patterns su...
-
Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation studyELISAs targeting RBD and S1 protein of SARS‐CoV‐2 are promising immunoassays which sha...
-
Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?The COVID‐19 vaccine developed by Pfizer and BioNTech was approved by the Medicines and ...
-
Postnatal SARS‐CoV‐2 Infection and Immunological Reaction: A Prospective Family Cohort StudyThe coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coro...
-
Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infectionWe also revealed that the alarmin HMGB1 is critical for SARS-CoV-2 replication. In contras...
-
Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19Coronavirus disease‐19 (COVID‐19) is a new disease caused by SARS‐CoV‐2. Since the...
-
Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – the 2020 COVID‐19 pandemic - A statement from the EAACI-Section on PediatricsMost countries affected by COVID‐19 have opted for nationwide confinement, which means t...
-
Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2Asthma and respiratory allergies have not been identified as risk factor for severe Covid-...
-
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsSARS‐CoV‐2 has triggered a pandemic that is now claiming many lives. Several studies h...
-
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohortThe PeARL multinational cohort included 1,054 children with asthma and 505 non‐asthmatic...
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma SectionAbstract Background The restrictions imposed by the COVID-19 pandemic impact heavily the m...
-
World Allergy Organization (WAO): Preparing your office for the COVID-19 PandemicAs COVID-19 continues to spread, it is important that we are ready to continue to care for...
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemicThe dynamically changing epidemiological situation related to SARS-CoV-2 infection poses c...
-
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma RegistryDespite the clinical burden of severe asthma is substantial, there is evidence of a neutra...
-
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 InfectionSARS-CoV-2 infection displays immense inter-individual clinical variability, ranging from ...
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticariaThe COVID‐19 pandemic dramatically disrupts health care around the globe. The impact of ...
-
SARS-COV-2 Candidate vaccines - composition, mechanisms of action and stages of clinical development Due to the extensive scientific‐industry collaborations the vaccine field is evolving at...
-
Thirty‐six COVID‐19 cases preventively vaccinated with mumps‐measles‐rubella vaccine: all mild courseThus, with the here presented cases we support the AMS declaration that MMR vaccination, a...
-
APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community CohortThis interesting article shows that the ApoE e4e4 allele increases risks of severe COVID-1...
-
Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recoverOur report suggests that XLA patients might present high risk to develop pneumonia after S...
-
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology ClinicIn the event of a global infectious pandemic, drastic measures may be needed that limit or...
-
Antibodies in serum of convalescent patients following mild COVID‐19 do not always prevent virus‐receptor bindingOur findings suggest that a natural SARS‐CoV‐2 infection, similar to that observed pre...
-
Shielding against SARS-CoV-2 infections is not justified in children with severe asthma For the EU‐funded project PERMEABLE (PERsonalized MEdicine Approach for asthma and aller...
-
Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic - An EAACI Position PaperIntranasal corticosteroids remain the standard treatment for CRS in patients with SARS‐C...
-
The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measuresThis allows the virus to bypass the efficient immune barrier of the upper airway mucosa in...
-
Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemicSputum induction (SI) is the gold standard approach to the non‐invasive study of airway ...
-
Elastase and Exacerbation of Neutrophil Innate Immunity are Involved in Multi‐Visceral Manifestations of COVID‐19Many arguments suggest that neutrophils could play a prominent role in COVID‐19. However...
-
First antibody trial launched in COVID-19 patientsThe article describes the initiation of the first clinical trial (ClinicalTrials.gov LY-Co...
-
The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemicMultisystem inflammatory syndrome in children (MIS‐C) during the COVID‐19 pandemic rai...
-
Enzymatic activity of ACE2 regulates type 2 airway inflammation in miceCoronavirus disease 2019 (COVID-19), caused by novel severe acute respiratory syndrome cor...
-
Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activationFollowing the emergency use authorization of the mRNA‐1273 vaccine on the 18thof Decembe...
-
SARS‐CoV‐2 infection in children – Understanding the immune responses and controlling the pandemicClear understanding of the immune responses to the virus in children and the transmission ...
-
The role of circulating eosinophils on COVID‐19 mortality varies by race/ethnicityDuring this rapidly moving international health crisis, varying and seemingly contrasting ...
-
Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreakWe found that a significant number of diseased did not develop relevant antibody responses...
Show more Covid-19 (49)Show Less-
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position PaperAbstract Further to the approval of the Coronavirus disease 2019 (COVID-19) vaccine BNT16...
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccinesAbstract The first approved COVID-19 vaccines include Pfizer/BioNTech BNT162B2, Moderna m...
-
The urgent need for a harmonized severity scoring system for acute allergic reactionsAbstract The accurate assessment and communication of the severity of acute allergic reac...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
Current practice of allergy diagnosis and the potential impact of regulation in EuropeAbstract In the European Union (EU), the regulatory framework regarding diagnostic allerg...
-
Omics technologies in allergy and asthma research: An EAACI position paperAbstract Allergic diseases and asthma are heterogenous chronic inflammatory conditions wit...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research prioritiesAbstract Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires bo...
-
Placebo effects in allergen immunotherapy - An EAACI Task Force Position PaperAbstract The placebo (Latin “I will please”) effect commonly occurs in clinic...
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants - An EAACI Position PaperAbstract It is well-established that food proteins, such as egg, soya, cow’s milk a...
-
The role of mobile health technologies in allergy care: An EAACI position paperAbstract Mobile health (mHealth) uses mobile communication devices such as smartphones an...
-
Hypersensitivity reactions to chemotherapy: an EAACI position paperAbstract Chemotherapeutic drugs have been widely used in the treatment of cancer disease ...
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendationsAbstract Immune modulation is a key therapeutic approach for allergic diseases, asthma an...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitisAbstract The prevalence of allergic diseases such as allergic rhinitis, asthma, food alle...
-
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paperAbstract The high prevalence of allergic diseases warrants for sufficient health care pro...
-
Hypersensitivity reactions to biological agents: An EAACI position paperAbstract Biologicals are crucial targeted therapeutic agents in oncological, immunologica...
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactionsAbstract Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy ...
-
Food processing and occupational respiratory allergy- An EAACI position paperAbstract Occupational exposure to foods is responsible for up to 25% of cases of occupati...
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic proceduresAbstract Beta-lactam (BL) allergy suspicion is common in children and constitutes a major...
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paperAbstract Allergy and respiratory disorders are common in young athletic individuals. In t...
-
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan - An EAACI position paperAbstract Diagnostic allergens are defined as medicinal products in the EU. Marketing auth...
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseasesAbstract Allergic diseases of the (upper and lower) airways, the skin and the gastrointes...
-
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force ReportAbstract Allergen exposure chambers (AECs) can be used for controlled exposure to allerge...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. In developed countries ...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
Management of anaphylaxis due to COVID-19 vaccines in the elderlyAbstract Older adults, especially men and/or those with diabetes, hypertension, and/or ob...
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children - EAACI position paperAbstract Gastro-oesophageal reflux (GOR) and food allergy (FA) are common conditions, esp...
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review - An EAACI position paperAbstract Drug hypersensitivity reactions (DHRs) are associated with high global morbidity...
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperAbstract Introduction In allergic asthma patients, one of the more common phenotypes might...
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task ForceAbstract Background: Guidelines for management of patients with allergic conditions are...
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position PaperAbstract Currently available European Alpine Altitude Climate Treatment (AACT) programs co...
-
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancerAbstract While desired for the cure of allergy, regulatory immune cell subsets and noncla...
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsAbstract Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific ...
-
Health effects of exposure to chlorination by - products in swimming poolsAbstract Concerns have been raised regarding the potential negative effects on human heal...
-
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas - An EAACI Task Force ReportAbstract Background: The effectiveness of allergen immunotherapy (AIT) in seasonal and ...
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisAbstract Nasal endoscopy is not only used for the diagnosis of chronic rhinosinusitis wit...
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part IAbstract Eicosanoids are biologically active lipid mediators, comprising prostaglandins, ...
-
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest GroupAbstract Women’s work has traditionally been considered less hazardous to health in...
-
The development of birch pollen seasons over 30 years in Munich, Germany - An EAACI task force reportThe global warming–oriented climate change is able to induce changes in the presentation...
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensusAbstract Background: Although there are many asymptomatic patients, one of the problems ...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
-
AllergoOncology: Microbiota in allergy and cancer - A European Academy for Allergy and Clinical Immunology position paperAbstract The microbiota can play important roles in the development of human immunity and...
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statementAbstract The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pande...
-
Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paperAbstract A recent survey of the European Academy of Allergy and Clinical Immunology (EAAC...
-
The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statementAbstract The vision of European Academy of Allergy and Clinical Immunology (EAACI) and th...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthmaAbstract To fully understand the role of diet diversity on allergy outcomes and to set st...
-
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"Abstract Background: Although there is a considerable body of knowledge about allergen ...
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergyAbstract An accurate diagnosis of β-lactam (BL) allergy can reduce patient morbidity and...
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria TaskforceAbstract Background: Although well described in adults, there are scarce and heterogene...
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paperAbstract Introduction: Adolescence is a critical stage of rapid biological, emotional a...
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practiceAbstract Most patients presenting with allergies are first seen by primary care health pr...
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European surveyAbstract Background: The European Academy of Allergy and Clinical Immunology has develo...
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paperAbstract Chronic airway diseases such as asthma and chronic obstructive pulmonary disease...
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paperAbstract Coronavirus disease 2019 (COVID-19), a respiratory tract infection caused by a n...
-
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position PaperAbstract The immune system interacts with many nominal ‘danger’ signals, endo...
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ ARIA Position PaperAbstract Background: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic...
-
Role of dietary fiber in promoting immune health - An EAACI position paperAbstract Microbial metabolism of specific dietary components, such as fiber, contributes ...
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needsAbstract In human patients with seasonal allergic rhinoconjunctivitis sensitized to grass...
-
Skin microdialysis: methods, applications and future opportunities - an EAACI position paperAbstract Skin microdialysis (SMD) is a versatile sampling technique that can be used to r...
-
Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspectiveAsthma is a complex heterogeneous disease characterized by bronchial hyperresponsiveness (...
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paperAbstract Drug hypersensitivity reactions (DHR) constitute a major and common public healt...
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paperAbstract Because of the inflammatory mechanisms of most chronic upper airway diseases suc...
-
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergyAbstract The aim of this survey was to explore the specific educational needs of a cohort...
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityAbstract Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the mo...
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic DiseasesAbstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the fi...
-
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paperAbstract Background: Food anaphylaxis is commonly elicited by unintentional ingestion o...
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatmentAbstract Insect venom allergy is the most frequent cause of anaphylaxis in Europe and poss...
-
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence NetworkAllergy, Asthma and Clinical Immunology Research has many challenges, including complex Eu...
-
Toward clinically applicable biomarkers for asthma: An EAACI position paperAbstract Inflammation, structural, and functional abnormalities within the airways are ke...
-
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergyAbstract Humans inhale, ingest, and touch thousands of fungi each day. The ubiquity and d...
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyAbstract Purpose: The European Academy of Allergy and Clinical Immunology (EAACI) has p...
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)Abstract Therapeutic advances using targeted biologicals and small-molecule drugs have ac...
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescentsAbstract Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatri...
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperAbstract Background: Chronic rhinosinusitis is regarded as a chronic airway disease. Acc...
-
